Scopus BioPharma Inc. Gains 50%
Tue, Sep 05, 2023 at 07:10 PM
Scopus BioPharma Inc. (SCPS:NASDAQ) rocketted at $0.06, representing a gain of 50%. On Tue, Sep 05, 2023, SCPS:NASDAQ touched a New 2-Week High of $0.06. From Tue, Aug 22, 2023, the stock recorded 28.57% Up Days and 0.00% Green Days
About Scopus BioPharma Inc. (SCPS:NASDAQ)
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system.
Top 10 Gainers:
- Verb Technology Company, Inc. (VERB:NASDAQ), 347.24%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 55.17%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 52.7%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 50%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 48.01%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 36.26%
- Akso Health Group (AHG:NASDAQ), 32.41%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 31.67%
- Digital Brands Group Inc. (DBGI:NASDAQ), 31.56%
- Applied Molecular Transport Inc. (AMTI:NASDAQ), 30.18%